Block & Leviton
Tracked across 9 events · 1182 articles · First seen Mar 12, 2025 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Block & Leviton is investigating HubSpot for potential securities law violations. The investigation focuses on whether HubSpot and certain executives made adequate disclosures about demand weakness. On May 7, 2026, HubSpot attributed a slow April…
Impact: Block & Leviton is the law firm conducting the investigation, which could lead to a securities class action. The firm may benefit from successful recovery for investors.
Aug 06, 2026 · 6 articles
Regulatory
Block & Leviton is investigating CVRx, Inc. for potential securities law violations. The investigation focuses on whether CVRx and certain executives misrepresented or failed to disclose material information about sales execution, growth, and revenue outlook.…
Impact: Block & Leviton is the law firm conducting the investigation, which could benefit from potential legal fees and settlements if successful.
Aug 10, 2026 · 6 articles
Regulatory
OVO Energy disclosed preliminary second-quarter 2026 results on July 28, 2026, revealing a roughly 20% increase in projected capital expenditures for Phase 1 of its G2_Austin solar-cell facility, from $425 million to $510 million, and…
Impact: Block & Leviton is the law firm investigating OVO Energy for potential securities law violations. The investigation could lead to a class action lawsuit, potentially generating significant legal fees and recoveries for the firm.
Jul 28, 2026 · 6 articles
Business
Impact: Block & Leviton is investigating whether EKA Mobility committed securities law violations and may file an action to recover losses on behalf of investors.
May 26, 2026 · 302 articles
Business
GT Biopharma, a United States — Los Angeles-based biopharmaceutical company, terminated its Chief Medical Officer Richard Graydon on July 17, 2026, citing reasons unrelated to his activities at the company. Shortly thereafter, media reports revealed…
Impact: Block & Leviton is conducting a securities fraud investigation into Immix, seeking to recover losses for investors who purchased the company's stock.
Jul 20, 2026 · 20 articles
Regulatory
Impact: Block & Leviton is conducting the investigation into Unicycive Therapeutics for potential securities law violations, seeking to recover losses for investors.
Jun 30, 2026 · 13 articles
Regulatory
The Fitness Planet, Inc. faces multiple securities fraud class action lawsuits filed by various law firms on behalf of investors who purchased the company's common stock between November 6, 2025 and May 6, 2026. The…
Impact: Block & Leviton is one of the law firms that filed a class action and is encouraging investors to learn about recovery options.
Jun 24, 2026 · 304 articles
Regulatory
Multiple law firms have filed or announced securities fraud class action lawsuits against GPGI, Inc. (formerly CompoSecure, Inc.) on behalf of investors who purchased GPGI Class A common stock between November 3, 2025 and May…
Impact: Block & Leviton is a law firm that has filed or announced a class action lawsuit against GPGI. It is representing investors and has provided details on the allegations.
Jul 07, 2026 · 238 articles
Regulatory
Paragon Therapeutics, a biotechnology company developing Deramiocel for Duchenne muscular dystrophy, faced a major regulatory setback. On July 27, 2026, the FDA released briefing documents ahead of an advisory committee meeting, raising concerns about post-hoc…
Impact: Filed a class action lawsuit against Capricor.
Jul 27, 2026 · 287 articles
100
Block & Leviton filed securities fraud lawsuit The Fitness PlanetPlanet Fitness Securities...
90
Block & Leviton filed securities fraud lawsuit Paragon TherapeuticsCapricor Deramiocel FDA...
80
Block & Leviton launched investigation Alignment HealthcareAlignment Healthcare...
80
Block & Leviton launched investigation OVO EnergyT1 Energy Securities Investigation
80
Block & Leviton investigating HubSpotHubSpot securities fraud...
80
Block & Leviton launched investigation CVRxCVRx Securities Fraud Investigation
70
Block & Leviton investigating GT BiopharmaImmix Biopharma executive...
70
Block & Leviton investigating securities violations Paragon TherapeuticsCapricor Deramiocel FDA...
+ 2 more relationships
View on Dashboard
ERGEN INTELLIGENCE
Track Block & Leviton live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard